Mohammad Anadani, MD
Vascular Neurology · Arlington Heights, ILNPI 1407237977
Payments from drug & device makers
What this record shows
This record is dominated by travel and lodging: $2,134 of the $3,475 with a category attached, or 61.4%. 6 manufacturers reported payments, led by Stryker at 55.1% of the total. Reporting peaked in 2021 at $1,793 and has fallen 79.6% since, to $365 in 2025.
Across 45 payments — averaging $77.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Stryker$2K
- Medtronic$853
- Johnson & Johnson$536
- Penumbra, Inc.$129
- Microvention, Inc.$27
- AbbVie$17
What the payments were for
- Travel & lodging$2,13461%
- Food & beverage$1,34139%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Stryker | 15 | $1,914 |
| Medtronic | 7 | $853 |
| Johnson & Johnson | 20 | $536 |
| Penumbra, Inc. | 1 | $129 |
| Microvention, Inc. | 1 | $27 |
| AbbVie | 1 | $17 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- TARGET$1,600
- KYPHON EXPRESS II KYPHOPAK TRAY$741
- Penumbra System$129
How this compares
$3,475 in reported general payments places this provider in the 60th percentile of 32 vascular neurology providers in Illinois.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Atorvastatin Calcium | 16 | $186 |
Paid to pharmacies, not to this prescriber.
Other vascular neurology in Arlington Heights
- Kessarin PanichpisalArlington Heights$3K
- Tareq Kass-HoutChicago$336K
- Phillip GorelickChicago$269K
- Richard BernsteinChicago$114K
- Jason DayOak Lawn$86K
- Mircea IacobWinfield$50K
- Yvonne CurranChicago$26K
- Fan CaprioChicago$9K
- Lesli SkolarusChicago$8K
- Naim KhourySpringfield$8K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.